PhD thesis (University of London, 2002):
“Anti-epileptic drugs: economic considerations in clinical practice”
The economic impact of anti-epileptic drugs was investigated using modelling techniques and also methods that incorporated patient preferences. Research was based on a large number of patient interviews performed within a clinical setting. Socio-economic factors were considered. Cost-effectiveness and cost-benefit analyses were performed. Overall, my research demonstrated that economic evaluation is most meaningful in clinical practice when it incorporates patient opinion.
Ridsdale L, et al Characteristics associated with quality of life among people with drug-resistant epilepsy.J Neurol. 2017 Jun;264(6):1174-1184
Amini,A… Heaney D Multiple sequential anti-body associated syndromes with a recurrent mutated neuroblastoma. Neurology 2016 87(6):
Baxendale S… Heaney D. The role of obesity in cognitive dysfunction in people with epilepsy. Epilepsy Behav. 2015 Apr;45:187-90
Zaccara G… Heaney DC. Network meta-analysis and the comparison of efficacy and tolerability of anti-epileptic drugs for treatment of refractory focal epilepsy. BJCP 2013 76(5):827-8
Baxendale S… Heaney D. Bright light therapy for symptoms of anxiety and depression in focal epilepsy: randomised controlled trial. Br J Psych. 2013 202(5):352-6
Baxendale S… Heaney D. Bright light therapy as an add on treatment for medically intractable epilepsy. Epi Behav. 2012 24(3):359-64
Baxendale S, Heaney D. Socioeconomic status, cognition, and hippocampal sclerosis. Epilepsy Behav. 2011 Jan;20(1):64-7.
Baxendale S, Heaney D, Thompson PJ, Duncan JS. Cognitive consequences of childhood-onset temporal lobe epilepsy across the adult lifespan. Neurology. 2010 Aug 24;75(8):705-11.
Adderley K. Low social class adversely affects outcome of epilepsy surgery. City of London MSc, awarded distinction. Supervised by Heaney D
Yuen AW, Singh R, Bell GS, Bhattacharjee A, Neligan A, Heaney DC, Duncan JS, Sander JW. The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre. Epilepsy Res. 2009 Dec;87(2-3):120-3.
Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain. 2009 Jan;132(Pt 1):156-71.
Yogarajah M, Powell HW, Heaney D, Smith SJ, Duncan JS, Sisodiya SM. Long term monitoring in refractory epilepsy: the Gowers Unit experience. J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):305-10.
Webb TE, Pal S, Siddique D, Heaney DC, Linehan JM, Wadsworth JD, Joiner S, Beck J, Wroe SJ, Stevenson V, Brandner S, Mead S, Collinge J. First report of Creutzfeldt-Jakob disease occurring in 2 siblings unexplained by PRNP mutation. J Neuropathol Exp Neurol. 2008 Sep;67(9):838-41.
Heaney DC, Bell GS, Sander JW. The socioeconomic, cultural, and emotional implications of starting or withholding treatment in a patient with a first seizure. Epilepsia. 2008; 49 Suppl 1:35-9 Heaney DC, Sander JW. “The unknown cost of epilepsy misdiagnosis in England and Wales”. Seizure. 2007 Jun;16(4):377
Heaney D, Sander JW. “Antiepileptic drugs: generic versus branded treatments”. Lancet Neurology 2007 May;6(5):465-8.
Chataway J, Porter B, Riazi A, Heaney D, Watt H, Hobart J, Thompson A. “Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial”. Lancet Neurology. 2006 Jul;5(7):565-71
Heaney D, Sander JWAS. Cost-effectiveness of Carbamazepine. Expert Review of Pharmaco-economics and Outcomes Research 2006 Vol. 6 No. 1 Pages 13-18
Farrell R??, Heaney D, Giovannoni?? G. Emerging disease modifying therapies for multiple sclerosis. Expert Opinion Emerging Drugs 2005, Vol. 10, No. 4, Pages 797-816
Heaney D, Swash M, Geddes M et al. Sarcoid polyneuropathy responsive to intravenous immunoglobulin. Muscle Nerve 2004; 29(3): 447-50
Heaney D et al. Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 2002; 325:1013-6.
Begley C et al. ILAE Commission on the Burden of Epilepsy, Subcommission on the Economic Burden of Epilepsy: Final report 1998-2001. Epilepsia 2002;43(6):668-73
MacDonald BK, Mummery CJ, Heaney D. Health needs of asylum seekers and refugees. Head injury needs to be taken into consideration in survivors of torture. BMJ 2001; 323:230
Book Chapters and Reports:
Heaney D, Williams D, O’Brien P – Neurological complications in pregnancy. In: De Swient’s Medical Disorders in Pregnancy. Ed Powrie, R et al. 2010
Heaney D, Shorvon SD. Epilepsy – Epidemiology, definitions and diagnostic procedures. In: Women with epilepsy – a handbook of health and treatment issues. Ed Morrell,M. 1st edition 2003
Heaney D, Sander JW. Cost benefit analysis in epilepsy. In: Epilepsy in Latin America. Ed. Devilat M, Campos M, Marinis A. 1st edition. Catholic University of Chile Press 2000
Shorvon SD, Thompson P, Heaney D. Epilepsy. In: Neurological Rehabilitation. Ed. Greenwood RJ, Barnes M, McMillan T, Ward D. 2nd edition. Churchill Livingstone Press 2000
Heaney D, Shorvon SD. Topiramate. In: A Handbook of Clinical Pharmacology. Ed. Eadie MJ. 2nd Edition.